These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8546401)

  • 1. Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA.
    Dalemans W; Delers A; Delmelle C; Denamur F; Meykens R; Thiriart C; Veenstra S; Francotte M; Bruck C; Cohen J
    Ann N Y Acad Sci; 1995 Nov; 772():255-6. PubMed ID: 8546401
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization against viral proteins with naked DNA.
    Ulmer JB; Donnelly JJ; Deck RR; DeWitt CM; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():117-25. PubMed ID: 8546384
    [No Abstract]   [Full Text] [Related]  

  • 3. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.
    Robinson HL; Hunt LA; Webster RG
    Vaccine; 1993; 11(9):957-60. PubMed ID: 8212843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of intramuscular immunization with naked DNA.
    Donnelly JJ; Ulmer JB; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():40-6. PubMed ID: 8546412
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model.
    Rota PA; De BK; Shaw MW; Black RA; Gamble WC; Kendal AP
    Virus Res; 1990 Apr; 16(1):83-93. PubMed ID: 2349834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses of mice inoculated with recombinant Lactobacillus plantarum NC8 expressing the fusion gene HA2 and 3M2e of the influenza virus and protection against different subtypes of influenza virus.
    Bo F; Yang WT; Shonyela SM; Jin YB; Huang KY; Shao LN; Wang C; Zhou Y; Li QY; Jiang YL; Huang HB; Shi CW; Wang JZ; Wang G; Kang YH; Yang GL; Wang CF
    Virus Res; 2019 Apr; 263():64-72. PubMed ID: 30611823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.
    Bender BS; Rowe CA; Taylor SF; Wyatt LS; Moss B; Small PA
    J Virol; 1996 Sep; 70(9):6418-24. PubMed ID: 8709274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.
    Olsen CW; McGregor MW; Dybdahl-Sissoko N; Schram BR; Nelson KM; Lunn DP; Macklin MD; Swain WF; Hinshaw VS
    Vaccine; 1997 Jul; 15(10):1149-56. PubMed ID: 9269061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules.
    Tamura S; Funato H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    Eur J Immunol; 1991 Jun; 21(6):1337-44. PubMed ID: 1646112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
    Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
    Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections.
    Hunt LA; Brown DW; Robinson HL; Naeve CW; Webster RG
    J Virol; 1988 Aug; 62(8):3014-9. PubMed ID: 2839718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus.
    Donnelly JJ; Friedman A; Martinez D; Montgomery DL; Shiver JW; Motzel SL; Ulmer JB; Liu MA
    Nat Med; 1995 Jun; 1(6):583-7. PubMed ID: 7585127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.